609780-68-9 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
PIPERIDINE-3-CARBOXYLIC ACID (4-CARBAMOYL-PHENYL)-AMIDE is utilized as a therapeutic agent in pharmaceutical research and drug development. Its unique structure allows it to potentially target and interact with specific biological systems, offering a promising avenue for the treatment of various conditions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, PIPERIDINE-3-CARBOXYLIC ACID (4-CARBAMOYL-PHENYL)-AMIDE is used for further study and exploration. Its properties and potential applications make it an important compound for understanding its role in biological interactions and for developing new therapeutic strategies.
Check Digit Verification of cas no
The CAS Registry Mumber 609780-68-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,9,7,8 and 0 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 609780-68:
(8*6)+(7*0)+(6*9)+(5*7)+(4*8)+(3*0)+(2*6)+(1*8)=189
189 % 10 = 9
So 609780-68-9 is a valid CAS Registry Number.
609780-68-9Relevant academic research and scientific papers
BENZAMIDE DERIVATIVES
-
, (2010/02/10)
A compound represented by formula (1): wherein X is a single bond or a substituted or unsubstituted lower alkylene group; Z is a saturated or unsaturated monocyclic hydrocarbon ring group or the like; and each of R1, R2, R3 and R4, which may be the same or different, is a hydrogen atom, a halogen atom, a nitro group, a cyano group, a carboxyl group, a substituted or unsubstituted alkyl group, or the like, a prodrug of said compound, or a pharmaceutically acceptable salt of said compound or prodrug has inhibitory effect on Rho kinase and hence is useful for treating diseases which are such that morbidity due to them is expected to be improved by inhibition of Rho kinase and secondary effects such as inhibition of the Na+/H+ exchange transport system caused by the Rho kinase inhibition, for example, hypertension.
